These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13356408)

  • 1. Studies on the control of hypertension. VI. Some evidence for reversal of the process during hexamethonium and hydralazine therapy.
    PERRY HM; SCHROEDER HA
    Circulation; 1956 Apr; 13(4):528-36. PubMed ID: 13356408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined hexamethonium, 1-hydrazinophthalazine and Rauwolfia serpentina therapy of arterial hypertension].
    FAERCHTEIN I
    Med Cir Farm; 1957; (250-251):72-86. PubMed ID: 13418006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immediate effect of apresoline & hexamethonium in ballistocardiography of patients with arterial hypertension].
    VALENTE JL
    Gaz Med Port; 1957; 10(1):86-98. PubMed ID: 13438179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Result of treatment of arterial hypertension with hexamethonium, thalazine & other drugs].
    VARELA DE SEIJAS AGUILAR J; FERNANDEZ ARENAS M; ESQUIVEL JIMENEZ A; MARCHAN COLADO A; DIAZ JM
    Rev Clin Esp; 1959 Feb; 72(4):242-4. PubMed ID: 13658634
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent reversal of severe systemic hypertension after prolonged toxic reaction to hydralazine.
    Miller AJ; Abrams DL; Kaplan BM
    Cardiology; 1975; 60(4):251-6. PubMed ID: 1225472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy.
    Perry HM; Schroeder HA; Catanzaro FJ; Moore-Jones D; Camel GH
    Circulation; 1966 Jun; 33(6):958-72. PubMed ID: 5940523
    [No Abstract]   [Full Text] [Related]  

  • 7. [Notes on neurolytic drugs in therapy of arterial hypertension].
    BRAUNER R; GALEA G; LACK H; DEMAYO A; NICOLAU V
    Med Interna (Bucur); 1958 Mar; 10(3):439-45. PubMed ID: 13551576
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyretotherapy and subcutaneous hexamethonium in the treatment of severe and malignant hypertension.
    ESPILDORA-LUQUE C; GONI F; ORTUZAR R; THOMSEN P; VIAL L
    Circulation; 1956 Mar; 13(3):351-9. PubMed ID: 13356393
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
    GOLDBERG B
    Lancet; 1957 Jan; 272(6959):74-7. PubMed ID: 13386278
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine.
    RAST CL; ORGAIN ES; MULLER JC; PRYOR WW; SIEBER HA
    Circulation; 1955 Sep; 12(3):361-9. PubMed ID: 13250698
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical observations on the oral use of hexamethonium, hydralazine, and rauwolfia extracts in essential hypertension.
    SALAND G; FISCHER I; HERNRIED HP; STOLIAR ED; ZURROW HB
    N Y State J Med; 1956 Apr; 56(8):1276-8. PubMed ID: 13309700
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient myopia during treatment for hypertension with autonomic blocking agents.
    GROSSMAN EE; HANLEY W
    Arch Ophthalmol; 1960 May; 63():853-5. PubMed ID: 13829698
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on angina pectoris during drug treatment of hypertension.
    HOLLANDER W; JUDSON WE; WILKINS RW
    Circulation; 1956 Apr; 13(4):553-61. PubMed ID: 13356411
    [No Abstract]   [Full Text] [Related]  

  • 14. Hexamethonium chloride with reserpine in the treatment of severe essential hypertension.
    LINDAUER MA; HAFKENSCHIEL JH
    Angiology; 1958 Feb; 9(1):19-23. PubMed ID: 13521392
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of antihypertensive drugs in dogs with angiotensin-induced hypertension.
    Tanz RD
    Proc Soc Exp Biol Med; 1971 Mar; 136(3):867-70. PubMed ID: 4324517
    [No Abstract]   [Full Text] [Related]  

  • 16. Pressor effect of subcutaneous renin in dogs, and effect of reserpine, 1-hydrazinophthalazine and hexamethonium on renin hypertension.
    HAYNES FW; DEXTER L
    Am J Physiol; 1959 Mar; 196(3):502-6. PubMed ID: 13627212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with hexamethonium salts in rectal administration in hypertension].
    ERLSBACHER O; GEISBERGER H
    Wien Klin Wochenschr; 1958 Mar; 70(11):192-3. PubMed ID: 13558113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rauwolfia serpentina extracts combined with hexamethonium in therapy of arterial hypertension in diabetics].
    DALLE COSTE P; KLINGER R
    Minerva Med; 1957 Feb; 48(16):634-8. PubMed ID: 13430477
    [No Abstract]   [Full Text] [Related]  

  • 19. Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine.
    GROB D; LANGFORD HG
    Circulation; 1953 Aug; 8(2):20. PubMed ID: 13067201
    [No Abstract]   [Full Text] [Related]  

  • 20. NEW approved drugs: hexamethonium bromide; hydralazine hydrochloride.
    Med Bull (Ann Arbor); 1952 Jun; 18(6):185-7. PubMed ID: 14950977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.